A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Targeted Antibody Blocking by a Dual-Functional Conjugate of Antigenic Peptide and Fc-III Mimetics (DCAF)

6.4K views

⸱

DOI:

10.3791/60063

⸱

September 17th, 2019

 ,  ,  ,  ,  ,  , 

* These authors contributed equally

In This Article

Summary

Development of a dual-functional conjugate of antigenic peptide and Fc-III mimetics (DCAF) is novel for the elimination of harmful antibodies. Here, we describe a detailed protocol for the synthesis of DCAF1 molecule, which can selectively block 4G2 antibody to eliminate antibody dependent enhancement effect during Dengue virus infection.

Abstract

Elimination of harmful antibodies from organisms is a valuable approach for the intervention of antibody-associated diseases, such as Dengue hemorrhagic fever and autoimmune diseases. Since thousands of antibodies with different epitopes are circulating in blood, no universal method, except for the dual-functional conjugate of antigenic peptide and Fc-III mimetics (DCAF), was reported to target specific harmful antibodies. The development of DCAF molecules makes significant contribution to the progress of targeted therapy, which were demonstrated to eliminate the antibody dependent enhancement (ADE) effect in a Dengue virus (DENV) infection model and to boost the acetylcholine receptor activity in a myasthenia gravis model. Here, we describe a protocol for the synthesis of a DCAF molecule (DCAF1), which can selectively block 4G2 antibody to attenuate ADE effect during Dengue virus infection, and illustrate the binding of DCAF1 to 4G2 antibody by an ELISA assay. In our method, DCAF1 is synthesized by the conjugation of a hydrazine derivative of a Fc-III peptide and a recombinant expressed long α-helix with antigenic sequence through native chemical ligation (NCL). This protocol has been successfully applied to DCAF1 as well as other DCAF molecules for targeting their cognate antibodies.

Introduction

Antibodies play important roles in humoral immune response for the neutralization of pathogenic bacteria and viruses1. However, some antibodies exhibit harmful impacts to the organisms, such as cross-reactive antibodies in the ADE effect during DENV infection and over-reactive antibodies in myasthenia gravis, which is an autoimmune diseases2,3. ADE effect is mediated by the cross-reactive antibodies that make the bridge to connect DENV and Fc receptor presenting cells4,5, while myasthenia gravis is caused by the excessive antibo....

Access restricted. Please log in or start a trial to view this content.

Protocol

1. Chemical synthesis of the hydrazine derivative of a Fc-III peptide

  1. Converting 2-Cl-(Trt)-Cl resin to 2-Cl-(Trt)-NHNH2 resin
    1. Weigh 625 mg of 2-Cl-(Trt)-Cl resin (0.25 mmol) into a 25 mL peptide synthesis vessel.
    2. Add 5 mL of N,N-dimethylformamide (DMF) to the resin from the top of the vessel, put the cap back, gently shake the vessel for 15 s and then drain it. Repeat DMF washing for two more times.
    3. Add 5 mL of dichloromethane (DCM) to the vessel, put the cap back, gently shake the vessel for 15 s and then drain it. Repeat DCM washing for two more times.
    4. Repeat step 1.1.2 three times....

Access restricted. Please log in or start a trial to view this content.

Results

The flowchart for the synthesis route by native chemical ligation in this article is shown in Figure 1. Figures 2-6 show the chromatograms (A) and mass spectra (B) of chemical synthesized hydrazine derivative of a Fc-III peptide, recombinant expressed linker and antigen part, the purified product from NCL reaction, the purified product from desulfurization reaction and the purified final product DCAF1, respectively. The chromatograms show th.......

Access restricted. Please log in or start a trial to view this content.

Discussion

The protocol here describes the semi-synthesis and detection of DCAF1 by using NCL approach, which is shown in Figure 1. Briefly, the two fragments of DCAF1 are chemical synthesized and recombinantly expressed, respectively; then, the full length DCAF1 molecule is assembled, modified and purified. For the hydrazine derived Fc-III fragment synthesis, using low-capacity 2-Cl resin is quite important, because high-capacity has a negative effect for hydrazine generation and leads to low yield of.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors have nothing to disclose.

Acknowledgements

This work was supported in part by the Tsinghua University-Gates Foundation (no. OPP1021992), the National Natural Science Foundation of China (no. 21502103, 21877068 and 041301475), and the National Key Research and Development Program of China (no. 2017YFA0505103).

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
2-Chlorotrityl resinTianjin Nankai HECHENG S&T
1-[Bis(dimethylamino)methylene]-1H-1,2,3-triazolo-[4,5-b]pyridinium hexafluorophosphate 3-oxideGL Biochem00703
2-(6-Chloro-1H-benzotriazole-1-yl)-1,1,3,3-tetramethylaminiumhexafluorophosphateGL Biochem00706
2,2′-Azobis[2-(2-imidazolin-2-yl)propane] dihydrochlorideJ&K Scientific503236
4G2 antibodyThermoMA5-24387
4-mercaptophenylacetic acidAlfa AesarH27658
96-well microtiter platesNEST701001
AcetonitrileThermo-FisherA955MS Grade
AgOAcSinopharm Chemical Reagent30164324
anti-GST antibodyAbclonalAE001
Anti-mouse IgG, HRP-linked AntibodyCell Signaling Technology7076P2
BSABeijing DINGGUO CHANGSHENG BOITECHNOL
CD spectrometerApplied Photophysics Ltd
dialysis bagSbjbioSBJ132636
DichloromethaneSinopharm Chemical Reagent80047360
diethyl etherSinopharm Chemical Reagent10009318
DNA Gel Extraction KitBeyotimeD0056
Fusion Lumos mass spectrometerThermo
GSH SepharoseGE Lifesciences
Guanidine hydrochlorideSinopharm Chemical Reagent30095516
Hydrazine hydrateSinopharm Chemical Reagent80070418
Hydrochloric acidSinopharm Chemical Reagent10011018
imidazoleSIGMA12399-100G
Isopropyl β-D-ThiogalactosideSIGMA5502-5G
kanamycinBeyotimeST101
MethanolThermo-FisherA456MS Grade
N, N-DiisopropylethylamineGL Biochem90600
N, N-DimethylformamideSinopharm Chemical Reagent8100771933
NcoIThermoER0571
PBS bufferSolarbioP1022
Peptide BEH C18 ColumnWaters186003625
piperidineSinopharm Chemical Reagent80104216
Plasmid Extraction KitSangon BiotechB611253-0002
QIAexpress KitQIAGEN32149
Rapid DNA Ligation KitBeyotimeD7002
Sodium dihydrogen phosphate dihydrateSinopharm Chemical Reagent20040718
Sodium hydroxideSinopharm Chemical Reagent10019762
Sodium nitriteSinopharm Chemical Reagent10020018
sodium chlorideSinopharm Chemical Reagent10019318
Standard Fmoc-protected amino acidsGL Biochem
sterilizing potTomySX-700
SUMO ProteaseThermo Fisher12588018
stop solutionBiolegend423001
the whole gene sequence that can express SUMO-linker-antigenTaihe Biotechnology Compay
TMB reagentBiolegend421101
Trifluoroacetic acidSIGMAT6508
TriisopropylsilaneGL Biochem91100
Tris(2-carboxyethyl)phosphine hydrochlorideAladdinT107252-5g
tryptoneOXOIDLP0042
Tween 20SolarbioT8220
Ultimate 3000 HPLCThermo
vacuum pumpYUHUASHZ-95B
XhoIThermoIVGN0086
yeast extractOXOIDLP0021

References

  1. Rhoades, R. A., Pflanzer, R. G. Human Physiology (4th ed.). , Thomson Learning. (2003).
  2. Halstead, S. B., O’Rourke, E. J. Antibody-enhanced dengue virus infection in primate leukocytes. Nature. 265, 739-741 (1977).
  3. Gammon, G., Sercarz, E.

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

Native Chemical LigationELISA AssayDengue VirusMyasthenia GravisPeptide SynthesisMass Spectrometry